Home  
  Our Team  
  Patient Info  
  Services  
   
  Pay My Bill  
  Contact Us  

News for Healthier Living

MOCCI-Driven Metabolic Reprogramming Promotes Lymph Node Metastasis in Lung Cancer

Lymph node metastasis is associated with poor prognosis in lung cancer, but the role of tumor metabolism in this process remains unclear. This study identifies a primary lymph node metastatic cancer cell (PLMC) subgroup characterized by MOCCI-driven oxidative phosphorylation (OXPHOS) reprogramming. MOCCI enhanced mitochondrial respiration in lung cancer cells and promoted lymph node metastasis in mice. Spatial analyses linked MOCCI-positive PLMCs, through GDF15-TGFBR2 signaling, to follicular helper T (Tfh) cell exhaustion and suppression of adjacent B-cell activation. The findings link metabolic adaptation to immune remodeling during dissemination and suggest a potential target for intercepting lymph node metastasis.

November 12, 2026


November 12 2026

November 11 2026

November 10 2026

November 9 2026

November 8 2026

November 7 2026

November 6 2026

November 5 2026

November 4 2026

November 3 2026

November 2 2026

November 1 2026

October 30 2026

October 29 2026